109 related articles for article (PubMed ID: 3045321)
1. Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 2.
Kruse CH; Holden KG; Offen PH; Pritchard ML; Feild JA; Rieman DJ; Bender PE; Ferguson B; Greig RG; Poste G
J Med Chem; 1988 Sep; 31(9):1768-72. PubMed ID: 3045321
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of multisubstrate inhibitors of an oncogene-encoded tyrosine-specific protein kinase. 1.
Kruse CH; Holden KG; Pritchard ML; Feild JA; Rieman DJ; Greig RG; Poste G
J Med Chem; 1988 Sep; 31(9):1762-7. PubMed ID: 2970550
[TBL] [Abstract][Full Text] [Related]
3. A truncated v-abl-derived tyrosine-specific tyrosine kinase expressed in Escherichia coli.
Pritchard ML; Rieman D; Feild J; Kruse C; Rosenberg M; Poste G; Greig RG; Ferguson BQ
Biochem J; 1989 Jan; 257(2):321-9. PubMed ID: 2539083
[TBL] [Abstract][Full Text] [Related]
4. Purification and characterization of a protein-tyrosine kinase encoded by the Abelson murine leukemia virus.
Foulkes JG; Chow M; Gorka C; Frackelton AR; Baltimore D
J Biol Chem; 1985 Jul; 260(13):8070-7. PubMed ID: 2989275
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tyrosine protein kinases by the antineoplastic agent adriamycin.
Donella-Deana A; Monti E; Pinna LA
Biochem Biophys Res Commun; 1989 May; 160(3):1309-15. PubMed ID: 2543396
[TBL] [Abstract][Full Text] [Related]
6. Isolation and analysis of an Abelson murine leukemia virus-encoded tyrosine-specific kinase produced in Escherichia coli.
Ferguson B; Pritchard ML; Feild J; Rieman D; Greig RG; Poste G; Rosenberg M
J Biol Chem; 1985 Mar; 260(6):3652-7. PubMed ID: 2982873
[TBL] [Abstract][Full Text] [Related]
7. Expression and purification of active abl protein-tyrosine kinase in Escherichia coli.
Rayter SI
Methods Enzymol; 1991; 200():596-604. PubMed ID: 1659661
[No Abstract] [Full Text] [Related]
8. An E. coli expression system for the rapid purification and characterization of a v-abl tyrosine protein kinase.
Lydon NB; Adams B; Poschet JF; Gutzwiller A; Matter A
Oncogene Res; 1990; 5(3):161-73. PubMed ID: 2157186
[TBL] [Abstract][Full Text] [Related]
9. Sulfonylbenzoyl-nitrostyrenes: potential bisubstrate type inhibitors of the EGF-receptor tyrosine protein kinase.
Traxler PM; Wacker O; Bach HL; Geissler JF; Kump W; Meyer T; Regenass U; Roesel JL; Lydon N
J Med Chem; 1991 Aug; 34(8):2328-37. PubMed ID: 1652014
[TBL] [Abstract][Full Text] [Related]
10. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.
Engelman A; Rosenberg N
J Virol; 1990 Sep; 64(9):4242-51. PubMed ID: 1696637
[TBL] [Abstract][Full Text] [Related]
11. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
Kamps MP; Sefton BM
Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of peanut serine/threonine/tyrosine protein kinase: molecular docking and inhibition kinetics with tyrosine kinase inhibitors.
Rudrabhatla P; Rajasekharan R
Biochemistry; 2004 Sep; 43(38):12123-32. PubMed ID: 15379551
[TBL] [Abstract][Full Text] [Related]
13. Structure and function of the Abelson murine leukemia virus transforming gene.
Wang JY; Prywes R; Baltimore D
Prog Clin Biol Res; 1983; 119():57-63. PubMed ID: 6306691
[TBL] [Abstract][Full Text] [Related]
14. Localization of tyrosine kinase-coding region in v-abl oncogene by the expression of v-abl-encoded proteins in bacteria.
Wang JY; Baltimore D
J Biol Chem; 1985 Jan; 260(1):64-71. PubMed ID: 2981223
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
[TBL] [Abstract][Full Text] [Related]
16. Nucleotide sequence of Abelson murine leukemia virus genome: structural similarity of its transforming gene product to other onc gene products with tyrosine-specific kinase activity.
Reddy EP; Smith MJ; Srinivasan A
Proc Natl Acad Sci U S A; 1983 Jun; 80(12):3623-7. PubMed ID: 6304726
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase inhibitors. 2. Synthesis of 2,2'-dithiobis(1H-indole-3-alkanamides) and investigation of their inhibitory activity against epidermal growth factor receptor and pp60v-src protein tyrosine kinases.
Thompson AM; Fry DW; Kraker AJ; Denny WA
J Med Chem; 1994 Mar; 37(5):598-609. PubMed ID: 7510340
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylinositol turnover and transformation of cells by Abelson murine leukaemia virus.
Fry MJ; Gebhardt A; Parker PJ; Foulkes JG
EMBO J; 1985 Dec; 4(12):3173-8. PubMed ID: 3004937
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of a series of flavones designed as inhibitors of protein tyrosine kinases.
Cunningham BD; Threadgill MD; Groundwater PW; Dale IL; Hickman JA
Anticancer Drug Des; 1992 Oct; 7(5):365-84. PubMed ID: 1388629
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the Abelson murine leukemia virus-encoded tyrosine-specific protein kinase.
Wang JY; Baltimore D
Methods Enzymol; 1983; 99():373-8. PubMed ID: 6196601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
